Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Laboratorios Farmacéuticos Rovi, S.A. has announced a modification to the securities and cash balances of its Liquidity Contract with Bestinver SV, S.A. Following the adjustment, the securities account will contain 6,000 shares, and the cash balance will stand at 570,000 euros.
For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.
